Alnylam Pharma (ALNY) Presents Positive RNAi Platform Data; Plans to Finalize NDC Selection
Go back to Alnylam Pharma (ALNY) Presents Positive RNAi Platform Data; Plans to Finalize NDC Selection| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 142.24 -1.56 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.80 | 52 Week High | $109.10 | |||
| Open | $143.00 | 52 Week Low | $31.38 | |||
| Day High | $143.49 | P/E | N/A | |||
| Day Low | $142.07 | EPS | $-1.45 | |||
| Volume | 56,359 | |||||
